Kangsheng Gu

8.1k total citations
119 papers, 1.8k citations indexed

About

Kangsheng Gu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Kangsheng Gu has authored 119 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Oncology, 47 papers in Pulmonary and Respiratory Medicine and 25 papers in Molecular Biology. Recurrent topics in Kangsheng Gu's work include Cancer Immunotherapy and Biomarkers (21 papers), Gastric Cancer Management and Outcomes (18 papers) and Colorectal Cancer Treatments and Studies (16 papers). Kangsheng Gu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (21 papers), Gastric Cancer Management and Outcomes (18 papers) and Colorectal Cancer Treatments and Studies (16 papers). Kangsheng Gu collaborates with scholars based in China, Japan and United States. Kangsheng Gu's co-authors include Yiyin Zhang, Yueyin Pan, Geng Song, Zhendong Chen, Hu Liu, Fuxing Xiong, Guoping Sun, Yang Jiao, Hua Wang and Guobing Xu and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Kangsheng Gu

104 papers receiving 1.7k citations

Peers

Kangsheng Gu
Kangsheng Gu
Citations per year, relative to Kangsheng Gu Kangsheng Gu (= 1×) peers Christophe Deben

Countries citing papers authored by Kangsheng Gu

Since Specialization
Citations

This map shows the geographic impact of Kangsheng Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kangsheng Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kangsheng Gu more than expected).

Fields of papers citing papers by Kangsheng Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kangsheng Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kangsheng Gu. The network helps show where Kangsheng Gu may publish in the future.

Co-authorship network of co-authors of Kangsheng Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Kangsheng Gu. A scholar is included among the top collaborators of Kangsheng Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kangsheng Gu. Kangsheng Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Yuhao, Kangsheng Gu, Huinan Che, & Yanhui Ao. (2025). Efficiently degradation of glyphosate and in-situ phosphorus recycle for promoting plant growth. Environmental Research. 278. 121720–121720. 1 indexed citations
2.
Cui, Lingfang, Kangsheng Gu, Huinan Che, Bin Liu, & Yanhui Ao. (2025). Marangoni effect-driven ultra-thin water layer on an arched evaporator for efficient clean water production. Chemical Engineering Journal. 521. 167059–167059. 1 indexed citations
3.
Cheng, Hui, Kangsheng Gu, Guangze Guo, et al.. (2025). Control strategy to improve sustainable flux for a high-solid AnMBR in co-digesting food waste and sewage sludge. Journal of Environmental Management. 392. 126652–126652.
4.
Guo, Wei, et al.. (2025). Properties enhancement of asphalt mortar incorporating phosphogypsum based on surface activation. Case Studies in Construction Materials. 22. e04251–e04251. 4 indexed citations
5.
Wu, Liangcai, Binkui Li, Yun Fan, et al.. (2025). 66P: Long-term follow-up of limertinib (ASK120067) in patients with locally advanced or metastatic EGFR T790M NSCLC: A multicentre, single-arm, phase IIb study. Journal of Thoracic Oncology. 20(3). S51–S52. 1 indexed citations
6.
Wu, Aimin, et al.. (2025). Nanozyme-synbiotics to improve iron-deficiency anemia. Colloids and Surfaces B Biointerfaces. 255. 114960–114960. 1 indexed citations
7.
Gu, Kangsheng, Peifang Wang, Huinan Che, et al.. (2025). Piezo-catalytic in-site H2O2 generation and activation across wide pH range to drive hydroxyl radical-mediated pollutant degradation. Nature Communications. 16(1). 7908–7908. 4 indexed citations
8.
Chen, Bangjie, et al.. (2024). mRNA vaccine development and applications: A special focus on tumors (Review). International Journal of Oncology. 65(2). 3 indexed citations
9.
Shen, Yuanyuan, et al.. (2024). Efficacy and safety of pegylated liposomal doxorubicin and epirubicin as neoadjuvant chemotherapy for breast cancer. Frontiers in Cell and Developmental Biology. 12. 1448037–1448037. 2 indexed citations
10.
Zhang, Qiang, Kangsheng Gu, Chaoran Dong, et al.. (2024). Polymeric Carbon Nitride Edged with Spatially Isolated Donor and Acceptor for Sunlight‐Driven H2O2 Synthesis and In‐Situ Utilization. Angewandte Chemie International Edition. 64(5). e202417591–e202417591. 33 indexed citations
11.
Qiu, Miao‐Zhen, Yuxian Bai, Jufeng Wang, et al.. (2024). Addition of SHR-1701 to first-line capecitabine and oxaliplatin (XELOX) plus bevacizumab for unresectable metastatic colorectal cancer. Signal Transduction and Targeted Therapy. 9(1). 349–349. 5 indexed citations
12.
Chen, Wenjun, et al.. (2023). Expression changes of ER, PR, HER2, and Ki-67 in primary and metastatic breast cancer and its clinical significance. Frontiers in Oncology. 13. 1053125–1053125. 11 indexed citations
13.
Hua, Qingling, et al.. (2023). KIAA1199 promotes oxaliplatin resistance and epithelial mesenchymal transition of colorectal cancer via protein O-GlcNAcylation. Translational Oncology. 28. 101617–101617. 9 indexed citations
14.
Wang, Qianling, Hui Wang, Yang Jiao, et al.. (2022). The Effect of Inflammatory Markers on the Survival of Advanced Gastric Cancer Patients Who Underwent Anti-Programmed Death 1 Therapy. Frontiers in Oncology. 12. 783197–783197. 26 indexed citations
15.
Peng, Zhi, Jia Wei, Wang Feng, et al.. (2021). Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as First-line Therapy for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma. Clinical Cancer Research. 27(11). 3069–3078. 75 indexed citations
16.
Xu, Jing, Lulu Fan, Wei Wei, et al.. (2019). Prognostic value of DNA aneuploidy in gastric cancer: a meta-analysis of 3449 cases. BMC Cancer. 19(1). 650–650. 5 indexed citations
17.
Zhang, Ying, et al.. (2018). The PD-1 rs36084323 A > G polymorphism decrease cancer risk in Asian: A meta-analysis. Pathology - Research and Practice. 214(11). 1758–1764. 13 indexed citations
19.
Wu, Hongyang, Zhendong Chen, Guoping Sun, et al.. (2009). Intravenous flurbiprofen axetil can increase analgesic effect in refractory cancer pain. Journal of Experimental & Clinical Cancer Research. 28(1). 33–33. 15 indexed citations
20.
Gu, Kangsheng. (2005). Measurement of normal apex pulmonis companion shadow on the chest film.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026